Financial Statements — CDNA
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 77.92 | 91.44 | 68.21 | 88.75 | 95.40 | 95.78 | 93.30 | 75.98 | 87.79 | 74.66 | 82.96 | 166.83 | 171.89 | 353.08 | 335.63 | 309.32 |
| Short-term Investments | 109.25 | 102.78 | 118.04 | 142.17 | 145.45 | 133.09 | 122.62 | 192.20 | 194.89 | 211.28 | 208.32 | 139.39 | 147.33 | 10.20 | 34.32 | 64.96 |
| Accounts Receivable | 44.59 | 47.84 | 67.36 | 71.49 | 66.63 | 66.16 | 60.15 | 51.69 | 51.63 | 59.31 | 70.43 | 70.14 | 65.32 | 56.18 | 48.07 | 43.36 |
| Inventory | 26.40 | 28.33 | 27.92 | 22.93 | 19.26 | 19.23 | 20.13 | 17.98 | 18.84 | 18.02 | 18.09 | 18.86 | 18.21 | 18.80 | 15.06 | 13.72 |
| Total Current Assets | 269.40 | 300.28 | 307.30 | 350.24 | 334.09 | 320.61 | 303.10 | 345.17 | 360.81 | 371.43 | 388.16 | 403.88 | 411.49 | 444.68 | 441.00 | 438.70 |
| Property, Plant & Equipment | 33.16 | 30.85 | 31.93 | 32.73 | 34.02 | 34.20 | 34.41 | 35.35 | 36.08 | 35.51 | 34.05 | 32.90 | 27.56 | 18.72 | 14.22 | 11.40 |
| Goodwill | 40.34 | 40.34 | 40.34 | 40.34 | 40.34 | 40.34 | 40.34 | 40.21 | 39.66 | 39.62 | 37.52 | 37.08 | 36.98 | 26.05 | 26.05 | 26.11 |
| Intangible Assets | 28.61 | 29.95 | 32.54 | 33.75 | 36.85 | 38.02 | 39.58 | 42.64 | 42.28 | 44.39 | 42.61 | 45.07 | 46.90 | 45.12 | 47.18 | 44.21 |
| Total Non-current Assets* | 141.67 | 132.03 | 136.96 | 139.40 | 142.90 | 146.17 | 149.31 | 156.01 | 154.01 | 156.79 | 156.35 | 137.41 | 135.22 | 118.50 | 116.42 | 102.52 |
| Total Assets | 411.06 | 432.31 | 444.26 | 489.64 | 476.99 | 466.78 | 452.41 | 501.18 | 514.82 | 528.22 | 544.51 | 541.29 | 546.71 | 563.17 | 557.42 | 541.22 |
| Accounts Payable | 9.07 | 11.60 | 9.86 | 8.07 | 6.24 | 5.87 | 9.98 | 8.97 | 9.88 | 12.86 | 10.63 | 16.89 | 10.61 | 14.89 | 12.56 | 11.60 |
| Total Current Liabilities | 79.15 | 99.04 | 93.18 | 85.28 | 81.44 | 78.33 | 70.21 | 72.67 | 74.50 | 71.83 | 70.29 | 78.46 | 66.92 | 69.74 | 56.26 | 45.73 |
| Long-term Debt | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Liabilities* | 18.37 | 22.12 | 23.71 | 25.01 | 122.30 | 123.78 | 125.97 | 34.37 | 35.11 | 36.37 | 37.54 | 19.28 | 22.25 | 21.29 | 21.32 | 23.95 |
| Total Liabilities | 97.53 | 121.17 | 116.89 | 110.29 | 203.74 | 202.11 | 196.18 | 107.05 | 109.61 | 108.20 | 107.83 | 97.74 | 89.17 | 91.03 | 77.57 | 69.68 |
| Retained Earnings | (732.55) | (719.05) | (695.16) | (636.59) | (704.25) | (696.84) | (695.45) | (534.20) | (509.90) | (484.88) | (441.47) | (424.53) | (402.84) | (367.04) | (355.14) | (353.21) |
| Total Stockholder Equity | 313.54 | 311.14 | 327.37 | 379.35 | 273.25 | 264.67 | 256.23 | 394.13 | 405.21 | 420.02 | 436.68 | 443.55 | 457.54 | 472.15 | 479.84 | 471.55 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Total Revenue | 117.70 | 108.39 | 100.06 | 86.68 | 84.69 | 86.58 | 82.88 | 92.27 | 72.05 | 65.57 | 67.19 | 70.30 | 77.26 | 82.38 | 79.36 | 80.63 | 79.42 | 79.22 | 75.59 | 74.19 |
| Research & Development | 21.42 | 19.31 | 16.77 | 16.83 | 18.52 | 16.53 | 17.49 | 19.68 | 18.71 | 18.28 | 19.00 | 20.23 | 24.36 | 23.57 | 22.31 | 22.63 | 21.88 | 22.05 | 19.44 | 19.04 |
| Selling, General & Admin | 30.48 | 28.68 | 28.43 | 27.68 | 22.77 | 40.68 | 28.52 | 27.68 | 26.91 | 26.54 | 33.97 | 29.33 | 28.03 | 24.78 | 23.83 | 25.23 | 26.56 | 24.75 | 18.67 | 16.32 |
| Total Operating Expenses | 116.50 | 114.43 | 100.30 | 97.80 | 98.06 | 11.89 | 93.38 | 96.37 | 91.39 | 188.20 | 95.98 | 97.93 | 101.59 | 101.50 | 96.70 | 102.35 | 98.47 | 94.62 | 84.32 | 78.93 |
| Operating Income | 1.20 | (6.04) | (0.25) | (11.12) | (13.37) | 74.69 | (10.49) | (4.10) | (19.34) | (122.63) | (28.78) | (27.62) | (24.32) | (19.12) | (17.34) | (21.72) | (19.05) | (15.40) | (8.73) | (4.74) |
| Pretax Income | 2.78 | (3.76) | 1.66 | (8.68) | (10.29) | 78.18 | (7.21) | (1.37) | (16.74) | (117.93) | (23.56) | (25.02) | (23.62) | (18.16) | (16.67) | (21.75) | (19.66) | (17.05) | (12.06) | (2.03) |
| Tax Provision | (0.03) | 0.35 | (0.01) | (0.12) | 0.06 | 0.17 | 0.20 | 0.02 | (0.08) | 0.17 | (0.08) | (0.07) | 0.12 | 0.17 | 0.27 | (0.05) | (0.01) | (0.90) | (0.16) | (0.10) |
| Net Income | 2.81 | (4.11) | 1.68 | (8.57) | (10.35) | 78.01 | (7.41) | (1.39) | (16.66) | (118.10) | (23.48) | (24.95) | (23.75) | (18.33) | (16.94) | (21.70) | (19.65) | (16.15) | (11.90) | (1.93) |
| Basic EPS | 0.05 | (0.08) | 0.03 | (0.16) | (0.19) | 1.49 | (0.14) | (0.03) | (0.32) | (2.21) | (0.43) | (0.46) | (0.44) | (0.34) | (0.32) | (0.41) | (0.37) | (0.31) | (0.23) | (0.04) |
| Diluted EPS | 0.05 | (0.08) | 0.03 | (0.16) | (0.19) | 1.42 | (0.14) | (0.03) | (0.32) | (2.21) | (0.43) | (0.46) | (0.44) | (0.34) | (0.32) | (0.41) | (0.37) | (0.31) | (0.23) | (0.04) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | 4.33 | 21.36 | 37.36 | 9.90 | (26.58) | 21.89 | 12.52 | 18.95 | (15.31) | (8.38) | (10.18) | (0.50) | 0.67 | 7.19 | (7.08) | (3.88) | (21.47) | 4.17 | 0.38 | 9.79 |
| Capital Expenditures | 3.82 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.80 | -- | -- | -- | -- | -- | -- | -- | 3.62 | 2.84 |
| Free Cash Flow* | 0.51 | -- | -- | -- | -- | -- | -- | -- | -- | -- | (11.98) | -- | -- | -- | -- | -- | -- | -- | (3.24) | 6.95 |
| Investing Cash Flow | 11.06 | (34.91) | 12.35 | 23.40 | 1.33 | (2.11) | (14.41) | (11.63) | 27.66 | 41.37 | (1.50) | 15.35 | (14.77) | 2.48 | (75.73) | 0.79 | (156.03) | (7.78) | 20.20 | 16.21 |
| Financing Cash Flow | (2.91) | (12.46) | (26.48) | (53.81) | (0.64) | (0.90) | 1.42 | (4.85) | (1.27) | (26.88) | (0.02) | (1.57) | (1.14) | (2.37) | (1.03) | (2.00) | 0.87 | (0.83) | (3.13) | 0.38 |
* Derived from reported values
